IL326537A - שיטה לטיפול בהתקפים - Google Patents

שיטה לטיפול בהתקפים

Info

Publication number
IL326537A
IL326537A IL326537A IL32653726A IL326537A IL 326537 A IL326537 A IL 326537A IL 326537 A IL326537 A IL 326537A IL 32653726 A IL32653726 A IL 32653726A IL 326537 A IL326537 A IL 326537A
Authority
IL
Israel
Prior art keywords
seizures
treatment
Prior art date
Application number
IL326537A
Other languages
English (en)
Original Assignee
Baergic Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baergic Bio Inc filed Critical Baergic Bio Inc
Publication of IL326537A publication Critical patent/IL326537A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL326537A 2023-08-16 2024-08-15 שיטה לטיפול בהתקפים IL326537A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363533059P 2023-08-16 2023-08-16
US202363548345P 2023-11-13 2023-11-13
PCT/US2024/042562 WO2025038882A2 (en) 2023-08-16 2024-08-15 Method for treatment of seizures

Publications (1)

Publication Number Publication Date
IL326537A true IL326537A (he) 2026-04-01

Family

ID=94633169

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326537A IL326537A (he) 2023-08-16 2024-08-15 שיטה לטיפול בהתקפים

Country Status (4)

Country Link
CN (1) CN121866054A (he)
AU (1) AU2024326320A1 (he)
IL (1) IL326537A (he)
WO (1) WO2025038882A2 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10538571B2 (en) * 2017-11-27 2020-01-21 Coda Biotherapeutics, Inc. Compositions and methods for neurological diseases
WO2019226820A1 (en) * 2018-05-22 2019-11-28 Neurocycle Therapeutics, Inc. Gabaa positive allosteric modulator compounds for treatment of itch and/ or dermatitis
EP3791873A1 (en) * 2019-09-16 2021-03-17 Universite De Bordeaux Methods of treatment and/or prevention of disorders and symptoms related to bkca and/or sk channelophathies

Also Published As

Publication number Publication date
CN121866054A (zh) 2026-04-14
AU2024326320A1 (en) 2026-02-12
WO2025038882A3 (en) 2025-05-15
WO2025038882A2 (en) 2025-02-20

Similar Documents

Publication Publication Date Title
IL315503A (he) שיטות לטיפול
IL325649A (he) שיטה לטיפול בדיכאון באמצעות סלטורקסנט
IL320711A (he) שיטות טיפול
EP4678604A4 (en) Method for resourceful treatment of phosphorus-containing wastewater
IL314620A (he) שיטה לטיפול באטרופיה אופטית
GB202201824D0 (en) Methods of treatment
IL326537A (he) שיטה לטיפול בהתקפים
EP4168013A4 (en) METHODS OF TREATMENT OF PANCREATITIS
CA3301694A1 (en) Method for treatment of seizures
EP4401839A4 (en) METHOD OF TREATMENT OF MULTIPLE MYELOMA
IL312155A (he) שיטה לטיפול בסרטן
GB202201825D0 (en) Methods of treatment
GB202201819D0 (en) Methods of treatment
GB202202876D0 (en) Method of treatment
GB202501677D0 (en) Method of treatment
GB202415301D0 (en) Method of treatment
GB202415306D0 (en) Method of treatment
GB202415300D0 (en) Method of treatment
GB202415299D0 (en) Method of treatment
GB202401177D0 (en) Method of treatment
GB202401180D0 (en) Method of treatment
GB202013074D0 (en) Method of treatment for cancer
GB202102950D0 (en) Method of treatment
GB202018243D0 (en) Method of treatment
GB202012436D0 (en) Method of treatment